Clinical Trials Browser

Phase 1/2 × Unresectable Metastatic Colorectal Cancer × 90 days × Clear all

NCT06934538 2025-12-22

First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer

Phase 1/2 Recruiting

Gastrointestinal

Unresectable Metastatic Colorectal Cancer